Michael M. Vanyukov
Center for Education and Drug Abuse Research
Department of Pharmaceutical Sciences
School of Pharmacy
University of Pittsburgh
USA
Name/email consistency: high
- Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. Vanyukov, M.M., Kirisci, L., Moss, L., Tarter, R.E., Reynolds, M.D., Maher, B.S., Kirillova, G.P., Ridenour, T., Clark, D.B. Behav. Genet. (2009)
- The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Vanyukov, M.M., Maher, B.S., Devlin, B., Kirillova, G.P., Kirisci, L., Yu, L.M., Ferrell, R.E. Psychiatr. Genet. (2007)
- Haplotypes of the monoamine oxidase genes and the risk for substance use disorders. Vanyukov, M.M., Maher, B.S., Devlin, B., Tarter, R.E., Kirillova, G.P., Yu, L.M., Ferrell, R.E. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2004)
- Liability to substance use disorders: 1. Common mechanisms and manifestations. Vanyukov, M.M., Tarter, R.E., Kirisci, L., Kirillova, G.P., Maher, B.S., Clark, D.B. Neurosci. Biobehav. Rev (2003)
- Liability to substance use disorders: 2. A measurement approach. Vanyukov, M.M., Kirisci, L., Tarter, R.E., Simkevitz, H.F., Kirillova, G.P., Maher, B.S., Clark, D.B. Neurosci. Biobehav. Rev (2003)
- Antisociality, substance dependence, and the DRD5 gene: a preliminary study. Vanyukov, M.M., Moss, H.B., Kaplan, B.B., Kirillova, G.P., Tarter, R.E. Am. J. Med. Genet. (2000)









